Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 19.55%17.92M | 20.55%16.14M | 4.03%12.69M | 4.18%54.16M | 54.16M | 14.99M | 13.39M | 12.2M | -8.39%51.98M | 8.59%56.74M |
| Cost of revenue | 38.02%11.04M | 35.59%10.33M | 12.15%8.27M | 12.31%31.4M | 31.39M | 8M | 7.62M | 7.37M | -2.59%27.96M | 3.32%28.7M |
| Gross profit | -1.57%6.88M | 0.69%5.81M | -8.40%4.42M | -5.27%22.76M | 22.77M | 6.99M | 5.77M | 4.82M | -14.32%24.03M | 14.56%28.04M |
| Operating expense | 8.56%4.47M | 25.18%4.65M | 26.62%4.15M | 39.11%14.91M | 13.7M | 4.11M | 3.71M | 3.28M | 4.52%10.72M | 24.39%10.26M |
| Staff costs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 19.66%7.15M | 23.75%5.98M |
| Selling and administrative expenses | 7.98%4.55M | 25.33%5.02M | 28.84%4.28M | 41.79%15.55M | --14.34M | --4.21M | --4.01M | --3.33M | 309.20%10.97M | 47.41%2.68M |
| -General and administrative expense | 7.98%4.55M | 25.33%5.02M | 28.84%4.28M | 41.79%15.55M | --14.34M | --4.21M | --4.01M | --3.33M | 309.20%10.97M | 47.41%2.68M |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -0.31%958K | -11.18%961K |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -0.31%958K | -11.18%961K |
| Rent and land expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1.57%129K | 15.45%127K |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 20.72%641K | 31.11%531K |
| Total other operating income | -16.84%79K | 27.21%374K | 191.11%131K | 157.96%638.09K | --638K | --95K | --294K | --45K | 1,136.78%247.36K | --20K |
| Operating profit | -16.06%2.42M | -43.51%1.16M | -82.83%265K | -41.01%7.85M | 9.07M | 2.88M | 2.06M | 1.54M | -25.18%13.31M | 9.57%17.79M |
| Net non-operating interest income (expenses) | 13.77%-914K | 35.17%-717K | -25.66%-1.38M | -19.33%-4.33M | -4.33M | -1.06M | -1.11M | -1.1M | -36.56%-3.63M | -17.21%-2.66M |
| Non-operating interest expense | -13.77%914K | -35.17%717K | 25.66%1.38M | 19.33%4.33M | --4.33M | --1.06M | --1.11M | --1.1M | 36.56%3.63M | 17.21%2.66M |
| Net investment income | 49K | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | -1.2M | -1.2M | 0 | -99.14%29K | |||||
| Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Less:Other special charges | ---- | ---- | ---- | ---- | --1.2M | ---- | --1.2M | ---- | -358.62%-133K | 99.18%-29K |
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | 27.21%374K | 191.11%131K | 157.96%638.09K | 638K | 95K | 294K | 45K | 292.63%247.36K | 0.00%63K | |
| Income before tax | -17.39%1.5M | -53.21%445K | -347.99%-1.11M | -63.62%3.52M | 3.54M | 1.82M | 951K | 448K | -36.40%9.68M | -13.03%15.22M |
| Income tax | -55.88%525K | 18.68%559K | -54.02%103K | 29.35%4.24M | 4.24M | 1.19M | 471K | 224K | 13.68%3.27M | -3.99%2.88M |
| Net income | 55.66%976K | -123.75%-114K | -641.96%-1.21M | -111.14%-713.61K | -700K | 627K | 480K | 224K | -48.09%6.41M | -14.90%12.34M |
| Net income continuous operations | 55.66%976K | -123.75%-114K | -641.96%-1.21M | -111.14%-713.61K | ---700K | --627K | --480K | --224K | -48.09%6.41M | -14.90%12.34M |
| Noncontrolling interests | -3K | -150.00%-1K | 78.96%-2.28K | -2K | 2K | -2K | -416.10%-10.86K | -58.83%3.43K | ||
| Net income attributable to the company | 56.14%979K | -123.64%-113K | -637.17%-1.21M | -111.08%-711.33K | -698K | 627K | 478K | 226K | -47.99%6.42M | -14.88%12.34M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 56.14%979K | -123.64%-113K | -637.17%-1.21M | -111.08%-711.33K | -698K | 627K | 478K | 226K | -47.99%6.42M | -14.88%12.34M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 60.00%0.0008 | -350.00%-0.001 | -631.91%-0.001 | -109.38%-0.06 | -0.0006 | 0.0005 | 0.0004 | 0.0002 | 6,123.86%0.64 | -14.88%0.0103 |
| Diluted earnings per share | 60.00%0.0008 | -350.00%-0.001 | -631.91%-0.001 | -109.38%-0.06 | -0.0006 | 0.0005 | 0.0004 | 0.0002 | 6,123.86%0.64 | -14.88%0.0103 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.